A study published by David Cheng, Postdoctoral Scientist, Neuroscience Research, University of New South Wales, NSW, Australia, says that CBD has a potential as a preventive measure against symptoms of Alzheimer’s. This presents yet another exciting development for medical researchers, given the persistent challenges to finding effective solutions for this condition.
We often cite research and articles intended to provide you with valuable health information. If we list a research link in our articles, blog postings, or social media accounts to a website where we sell products or have product information, the exit disclaimer indicates that when you click a link you will leave the DiscoverCBD.com website and visit an external link. Links to any informational websites are provided solely as a service to our users. External links provide additional information that may be useful or interesting and have no affiliation to the promotion, sale and distribution of DiscoverCBD.com or its affiliated companies products. The link does not constitute an endorsement of these organizations by DiscoverCBD.com or its affiliated companies and none should be inferred.
Today, it’s mostly used as a supplement that promotes overall health and has anticonvulsant, anti-inflammatory, and anti-anxiety properties. CBD is also recommended as a natural pain relief medicine. It has been reported to aid the relief of severe conditions like cancer and AIDS. Furthermore, CBD can lessen the negative side effects of the chemotherapy treatment.
For example, both CBD and THC affect the body’s endocannabinoid system and thus provide relief for many of the same conditions. CBD is used for more “serious ailments.” Including but not limited to seizures, psychosis or mental disorders and inflammatory bowel disease. The reason for that is that CBD doesn’t get you “high.” In fact, it would be impossible for a person to get high while using CBD because as we said above, it interferes with the CB1 receptors.
A number of difficulties exist in evaluating published data on CBD or marijuana use for epilepsy. The extremely limited published studies were small, poorly described, and not well designed. Contributing to the difficulty of interpreting published studies, CBD products are not produced under the guidance of good manufacturing practices (GMP) and are not subject to regulations governing labeling, purity, and reliability. In other words, currently, there is no guarantee of consistency between products, or even differing lots produced by the same manufacturer. Without independent testing (e.g. USP certification) of CBD products for content and purity, as well as bioavailability testing of specific products, uncertainty surrounds the use of available CBD products in routine clinical settings.
The contents displayed within this public group(s), such as text, graphics, and other material ("Content") are intended for educational purposes only. The Content is not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your healthcare provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in a public group(s).
Both CB1 and CB2 helps your ECs to regulate your inflammation levels, pain levels, immune functions, sleep, digestion, appetite, memory, mood, and other functions. It makes an impact exactly where needed to create balance and homeostasis. Once they achieve balance in your body, enzymes break them down so they don’t cause any damage or disrupt the balance in the opposite direction.
Recent studies – in addition to new medication options that include CBD – have also shown promising results in various forms of epilepsy, including Dravet Syndrome. In summary findings published by the U.S. National Library of medicine, multiple small clinical trials have shown that CBD is able to reduce the number of seizures and severity of seizures for those that experience specific forms of epilepsy on a regular basis. (9)
‘CBD has proven anti-anxiety effects and may be helpful in depression, based on anecdotal reports,’ says Dr Gordon. ‘I use high CBD prescription cannabis medicine products as part of a mental health protocol with my patients suffering with anxiety and depression. The antidepressant effects of CBD have been shown in animal models, but we now need large, depression-specific studies in humans as the next step.’
CBD is one of over 60 compounds found in cannabis that belong to a class of ingredients called cannabinoids. Until recently, THC (tetrahydrocannabinol) was getting most of the attention because it’s the ingredient in cannabis that produces intoxicating effects in users. But CBD is also present in high concentrations — and the world is awakening to its possible benefits.